An assessment tool for predicting fracture risk in postmenopausal women.
about
Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal womenEtidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal womenRisedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal womenPopulation-based fracture risk assessment and osteoporosis treatment disparities by race and genderFRAX and the assessment of fracture probability in men and women from the UKLow bone mineral density and fracture burden in postmenopausal womenDiscordant effect of body mass index on bone mineral density and speed of soundEvaluation of easily measured risk factors in the prediction of osteoporotic fractures.Fracture risk in long term care: a systematic review and meta-analysis of prospective observational studiesMind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures.Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial.Two years of Denosumab and teriparatide administration in postmenopausal women with osteoporosis (The DATA Extension Study): a randomized controlled trial.Comparative effects of teriparatide, denosumab, and combination therapy on peripheral compartmental bone density, microarchitecture, and estimated strength: the DATA-HRpQCT StudyDenosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial.Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study)Development of a Korean Fracture Risk Score (KFRS) for Predicting Osteoporotic Fracture Risk: Analysis of Data from the Korean National Health Insurance Service.FRAX®: prediction of major osteoporotic fractures in women from the general population: the OPUS study.Timing and risk factors for clinical fractures among postmenopausal women: a 5-year prospective studyValidation of a 4-item score predicting hip fracture and mortality risk among elderly women.Hip and fragility fracture prediction by 4-item clinical risk score and mobile heel BMD: a women cohort study.Development and validation of a population-based prediction scale for osteoporotic fracture in the region of Valencia, Spain: the ESOSVAL-R study.Development of a prediction tool for low bone mass based on clinical data and periapical radiography.Hip protectors: recommendations for conducting clinical trials--an international consensus statement (part II)The 'Ossebo' intervention for the prevention of injurious falls in elderly women: background and design.Improving bone strength prediction in human proximal femur specimens through geometrical characterization of trabecular bone microarchitecture and support vector regression.Psychological state, quality of life, and body composition in postmenopausal women with osteoporosis in LithuaniaPatient perceptions of osteoporosis treatment thresholdsA randomized study of the effect of 5-year and lifetime hip fracture risk information on physician recommendations for management of low bone density.Clinical value of prognostic instruments to identify patients with an increased risk for osteoporotic fractures: systematic review.The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.Osteoporosis and risk of fracture, analysis on a population admitted in rehabilitation post-acute.The 2002 Canadian bone densitometry recommendations: take-home messages.Updated recommendations for the diagnosis and management of osteoporosis: a local perspectiveFragile fracture care management programFracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX toolEffective risk assessment tools for osteoporosis in the Indian menopausal female.Preference for hip protectors among older adults at high risk for osteoporotic fractures.Mikkeli Osteoporosis Index Identifies Fracture Risk Factors and Osteoporosis and Intervention Thresholds Parallel with FRAX.Association between Body Mass Index and Bone Mineral Density in Patients Referred for Dual-Energy X-Ray Absorptiometry Scan in Ajman, UAE.Patient treatment preferences for osteoporosis
P2860
Q24242258-6162342F-A45F-4447-8C57-49E950B15C21Q24242665-7A649AA1-A318-40C9-B7AF-0268F33B1C78Q24242674-FE02F043-A3FE-4E30-AF9F-0DF439CD0751Q24648952-15FECFBE-150A-4504-A576-358E9CE3DB3EQ24654123-D10F5ABB-2CCB-4D79-B653-1BF28AF1560CQ24671503-768A954E-1A14-4C56-9AE8-BF3F89A82736Q24793822-96161CE5-1C52-4390-A6A9-74FA5FB75984Q24813492-42676242-01B3-4983-B622-E1C16684E147Q26853714-71FAE37B-92D7-4011-A3A9-758842E1102CQ30236007-D70F5B53-D02D-41E4-AA45-673521E7790AQ30627873-93D54DB1-989A-4FAF-A618-3C6A530DFF13Q30755058-EBBC0ADC-7614-4159-B2B3-1F9D9443E62CQ30837472-F26D836B-0025-41A8-9CA7-1C207B22115CQ30978614-81B58A65-247F-47A7-BF0B-93998BA96780Q31056665-0E41B19D-611C-4102-85F8-02525B1479E5Q31113782-240934B3-45A8-4D2C-9598-A28BC5FF97E5Q31147039-5AB20A5F-462B-49B3-95EC-28433E97EC39Q33259826-58BB688F-7294-4AF6-AE46-EAC203326321Q33270814-6C506623-8B1D-4919-A777-8C5A5D33A510Q33545414-89B96F93-5618-4910-B0F4-C2A2F8238F3BQ33545420-7AF2D759-23DD-46B5-8029-A6DAA18077CFQ33556347-252E47B9-9CFB-4A4A-82C5-8FB5E2532B35Q33610045-8739C115-F60F-4C5C-9BF4-FC553268C352Q33618295-3953367D-906E-4D9A-B2F3-CFE08D2E1525Q33648627-18872DA3-CF08-44FE-B10A-00A89EAFCCE8Q33720247-E1260FD0-0565-405D-946B-32CAD7910757Q33766971-76F63F96-4EA7-47FD-A15B-74A86B4F87F1Q33902507-17BBE0FF-DCCB-43FC-83FF-476C6E1EC4E7Q33916708-AD056166-29A4-4E7E-8DA7-FE98FB472386Q34152778-EAAFDBE0-D581-4D54-90D6-F552C4F628C7Q34230327-FEE91BCD-10D4-4A9D-BE68-FF0F516A6416Q34292278-E7CB805E-33D7-45FB-8C7A-C21FA1916D4EQ35008617-885E4395-6AB8-4B04-BF9C-A8B612AEE6FAQ35025600-3C6DDF55-E2B0-4815-8365-19CB27429DFAQ35037792-62B55093-8038-44D9-B1B1-B18856DBB3D1Q35066049-32CDB38A-74E2-4450-8F9A-9E05B716D334Q35098210-E433900D-8FF9-467C-ACBB-9B0F11DFCE06Q35101980-727DE466-43EF-4886-A763-CBE7F52A2528Q35102022-528C6EFF-91E9-488E-BB14-8361AB81D094Q35112445-82FB9C1C-32F0-467C-ACA6-7099E7247DCB
P2860
An assessment tool for predicting fracture risk in postmenopausal women.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
An assessment tool for predicting fracture risk in postmenopausal women.
@en
An assessment tool for predicting fracture risk in postmenopausal women.
@nl
type
label
An assessment tool for predicting fracture risk in postmenopausal women.
@en
An assessment tool for predicting fracture risk in postmenopausal women.
@nl
prefLabel
An assessment tool for predicting fracture risk in postmenopausal women.
@en
An assessment tool for predicting fracture risk in postmenopausal women.
@nl
P2093
P356
P1476
An assessment tool for predicting fracture risk in postmenopausal women.
@en
P2093
P2888
P304
P356
10.1007/S001980170072
P407
P577
2001-01-01T00:00:00Z